$AREN
Arena Group Holdings, Inc. Stock $aren

$aren Overview Financials Valuation SEC Filings Company Website

2016 Q3 Form 10-Q Financial Statement

#000114420416119184 Filed on August 15, 2016

Income Statement

Concept	2016 Q3	2016 Q2	2015 Q4
Revenue	$0.00	$0.00	$0.00
YoY Change
Cost Of Revenue	$0.00
YoY Change
Gross Profit	$0.00
YoY Change
Gross Profit Margin
Selling, General & Admin	$1.110M	-$70.00K	$50.00K
YoY Change	2120.0%	-216.67%	0.0%
% of Gross Profit
Research & Development	$374.9K
YoY Change
% of Gross Profit
Depreciation & Amortization	$0.00
YoY Change
% of Gross Profit
Operating Expenses	$374.9K	-$70.00K	$50.00K
YoY Change	649.89%	-216.67%	0.0%
Operating Profit	-$1.485M	-$50.88K
YoY Change	2892.35%	-9.71%
Interest Expense	$4.044K	$0.00	$10.00K
YoY Change		-100.0%
% of Operating Profit
Other Income/Expense, Net	-$4.044K	$7.514K
YoY Change	63.0%	25.23%
Pretax Income	-$1.490M	$70.00K	-$30.00K
YoY Change	2880.0%	-239.03%	-40.0%
Income Tax	$0.00		$0.00
% Of Pretax Income
Net Earnings	-$1.489M	$70.00K	-$30.00K
YoY Change	2757.68%	-236.86%	-40.0%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share	-$7.84	$0.17	-$0.08
COMMON SHARES
Basic Shares Outstanding	9.484M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2016 Q3	2016 Q2	2015 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$1.600M	$2.300M	$2.300M
YoY Change	-30.43%	-4.17%	-8.0%
Cash & Equivalents	$149.3K	$863.0K	$0.00
Short-Term Investments	$1.100M	$1.400M	$1.800M
Other Short-Term Assets	$0.00	$12.80K	$29.93K
YoY Change		-24.48%	2.34%
Inventory
Prepaid Expenses
Receivables	$600.0K
Other Receivables	$0.00
Total Short-Term Assets	$2.300M	$2.267M	$2.352M
YoY Change	-4.17%	-5.85%	-6.09%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$0.00	$0.00	$0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets	$2.300M	$2.267M	$2.352M
Total Long-Term Assets	$0.00	$0.00	$0.00
Total Assets	$2.300M	$2.267M	$2.352M
YoY Change	-4.17%	-5.85%	-6.09%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$100.0K	$111.00	$9.631K
YoY Change		-98.77%	-46.49%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$200.0K	$85.65K	$85.97K
YoY Change	100.0%	6.63%	-3.17%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$0.00	$0.00	$0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$200.0K	$85.65K	$85.97K
Total Long-Term Liabilities	$0.00	$0.00	$0.00
Total Liabilities	$200.0K	$100.0K	$100.0K
YoY Change	100.0%	0.0%	0.0%
SHAREHOLDERS EQUITY
Retained Earnings		-$62.64M	-$62.53M
YoY Change		0.32%	0.32%
Common Stock			$92.83K
YoY Change			3.72%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$0.00	$2.013M	$2.097M
YoY Change
Total Liabilities & Shareholders Equity	$2.300M	$2.267M	$2.352M
YoY Change	-4.17%	-5.85%	-6.09%

Cashflow Statement

Concept	2016 Q3	2016 Q2	2015 Q4
OPERATING ACTIVITIES
Net Income	-$1.489M	$70.00K	-$30.00K
YoY Change	2757.68%	-236.86%	-40.0%
Depreciation, Depletion And Amortization	$0.00
YoY Change
Cash From Operating Activities	-$410.0K	-$50.00K	-$10.00K
YoY Change	583.33%	-16.67%	0.0%
INVESTING ACTIVITIES
Capital Expenditures	$0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities		$230.0K	$230.0K
YoY Change		-146.0%	-866.67%
Cash From Investing Activities	-$400.0K	$230.0K	$230.0K
YoY Change	-322.22%	-146.0%	-866.67%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	640.0K
YoY Change
NET CHANGE
Cash From Operating Activities	-410.0K	-50.00K	-10.00K
Cash From Investing Activities	-400.0K	230.0K	230.0K
Cash From Financing Activities	640.0K
Net Change In Cash	-170.0K	180.0K	220.0K
YoY Change	-241.67%	-132.14%	-650.0%
FREE CASH FLOW
Cash From Operating Activities	-$410.0K	-$50.00K	-$10.00K
Capital Expenditures	$0.00
Free Cash Flow	-$410.0K
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	us-gaap	Net Income Loss NetIncomeLoss	-116528	USD
CY2015Q4	us-gaap	Available For Sale Securities AvailableForSaleSecurities	1776185	USD
CY2016Q2	us-gaap	Incremental Common Shares Attributable To Conversion Of Preferred Stock IncrementalCommonSharesAttributableToConversionOfPreferredStock	1238941	shares
	us-gaap	Incremental Common Shares Attributable To Conversion Of Preferred Stock IncrementalCommonSharesAttributableToConversionOfPreferredStock	1321537	shares
	us-gaap	Incremental Common Shares Attributable To Conversion Of Preferred Stock IncrementalCommonSharesAttributableToConversionOfPreferredStock	1238941	shares
CY2015Q4	us-gaap	Liabilities Current LiabilitiesCurrent	85974	USD
CY2016Q2	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	168496	USD
CY2016Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	862990	USD
CY2015Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	545705	USD
CY2016Q2	us-gaap	Available For Sale Securities Current AvailableForSaleSecuritiesCurrent	1391154	USD
CY2015Q4	us-gaap	Available For Sale Securities Current AvailableForSaleSecuritiesCurrent	1776185	USD
CY2016Q2	us-gaap	Other Assets Current OtherAssetsCurrent	12797	USD
CY2015Q4	us-gaap	Other Assets Current OtherAssetsCurrent	29928	USD
CY2016Q2	us-gaap	Assets Current AssetsCurrent	2266941	USD
CY2015Q4	us-gaap	Assets Current AssetsCurrent	2351818	USD
CY2016Q2	us-gaap	Assets Assets	2266941	USD
CY2015Q4	us-gaap	Assets Assets	2351818	USD
CY2016Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	111	USD
CY2015Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	9631	USD
CY2016Q2	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	85537	USD
CY2015Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	76343	USD
CY2016Q2	us-gaap	Liabilities Current LiabilitiesCurrent	85648	USD
CY2015Q4	us-gaap	Common Stock Value CommonStockValue	92829	USD
CY2016Q2	issm	Common Stock Value To Be Issued CommonStockValueToBeIssued	9375	USD
CY2015Q4	issm	Common Stock Value To Be Issued CommonStockValueToBeIssued	12500	USD
CY2016Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	64534632	USD
CY2015Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	64514177	USD
CY2016Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-62643982	USD
CY2016Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	18523	USD
CY2015Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-62527454	USD
CY2015Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	5296	USD
CY2016Q2	us-gaap	Stockholders Equity StockholdersEquity	2012797	USD
CY2015Q4	us-gaap	Stockholders Equity StockholdersEquity	2097348	USD
CY2016Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2266941	USD
CY2015Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2351818	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	118891	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	130054	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-118891	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-130054	USD
	us-gaap	Investment Income Net InvestmentIncomeNet	9551	USD
	us-gaap	Investment Income Net InvestmentIncomeNet	17945	USD
	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	-9194	USD
	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	-538	USD
	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	2806	USD
	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	1517	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	3163	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	18924	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-115728	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-111130	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	800	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	800	USD
	us-gaap	Net Income Loss NetIncomeLoss	-111930	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	16033	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	430	USD
	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-103301	USD
	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-113105	USD
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.01
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.01
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.01
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.01
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	9386712	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	9065208	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	9386712	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	9065208	shares
	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax	2806	USD
	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax	1605	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-1175	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	13227	USD
CY2016Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	50878	USD
CY2016Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-50878	USD
CY2016Q2	us-gaap	Investment Income Net InvestmentIncomeNet	5186	USD
CY2016Q2	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	134	USD
CY2016Q2	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	2194	USD
CY2016Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	7514	USD
CY2015Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	6000	USD
CY2016Q2	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	4941	USD
CY2015Q2	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-351	USD
CY2016Q2	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-40617	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-332448	USD
CY2014Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	542215	USD
CY2015Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	209767	USD
	us-gaap	Availableforsale Securities Gross Unrealized Gain Loss1 AvailableforsaleSecuritiesGrossUnrealizedGainLoss1	13227	USD
	us-gaap	Availableforsale Securities Gross Unrealized Gain Loss1 AvailableforsaleSecuritiesGrossUnrealizedGainLoss1	-1175	USD
	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	9375	USD
	issm	Stock To Be Issued During Period Value Common Stock StockToBeIssuedDuringPeriodValueCommonStock	9375	USD
CY2016Q2	issm	Available For Sale Securities Debt Maturities After One Through Three Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue	222476	USD
CY2016Q2	issm	Available For Sale Securities Debt Maturities After Three Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterThreeYearsFairValue	181046	USD
CY2015Q2	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-53177	USD
CY2016Q2	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax	2194	USD
CY2015Q2	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax	1677	USD
CY2015Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-2028	USD
CY2016Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	2747	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	18750	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	25000	USD
	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-17131	USD
	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-12299	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-9520	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-9000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-83779	USD
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-84610	USD
	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	0	USD
	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	1067592	USD
	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	401064	USD
	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	819754	USD
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	401064	USD
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-247838	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	317285	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-103301	USD
CY2016Q2	issm	Checking Account CheckingAccount	116000	USD
CY2016Q2	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	USD
CY2016Q2	us-gaap	Money Market Funds At Carrying Value MoneyMarketFundsAtCarryingValue	747000	USD
CY2016Q2	us-gaap	Asset Backed Securities At Carrying Value AssetBackedSecuritiesAtCarryingValue	250000	USD
CY2016Q2	us-gaap	Available For Sale Securities Debt Maturities Within One Year Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost	975209	USD
CY2016Q2	issm	Available For Sale Securities Debt Maturities After One Through Three Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsAmortizedCost	220371	USD
CY2016Q2	issm	Available For Sale Securities Debt Maturities After Three Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterThreeYearsAmortizedCost	177051	USD
CY2016Q2	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	987632	USD
CY2016Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
	us-gaap	Increase Decrease In Derivative Liabilities IncreaseDecreaseInDerivativeLiabilities	9194	USD
CY2016Q1	issm	Stock Issuance Date StockIssuanceDate	2016-01-11
CY2016Q1	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	83334	shares
CY2016Q1	issm	Stock Issued During Period Per Share Value Of New Issues StockIssuedDuringPeriodPerShareValueOfNewIssues	0.15
CY2016Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	12500	USD
CY2016Q2	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	58594	shares
CY2016Q2	us-gaap	Deferred Compensation Liability Current DeferredCompensationLiabilityCurrent	25000	USD
	dei	Document Type DocumentType	10-Q
	dei	Amendment Flag AmendmentFlag	false
CY2016Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	9424909	shares
CY2016Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	9424909	shares
CY2016Q2	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1	0.17
	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2	P2Y10M17D
CY2016Q2	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1	0.17
CY2016Q2	issm	Stock Issued During Period Per Share Value Of New Issues StockIssuedDuringPeriodPerShareValueOfNewIssues	0.16
CY2016Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	9375	USD
	dei	Document Period End Date DocumentPeriodEndDate	2016-06-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2016
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Entity Registrant Name EntityRegistrantName	INTEGRATED SURGICAL SYSTEMS INC
	dei	Entity Central Index Key EntityCentralIndexKey	0000894871
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Entity Filer Category EntityFilerCategory	Smaller Reporting Company
	dei	Trading Symbol TradingSymbol	ISSM
CY2016Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	9483503	shares
CY2016Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2015Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2016Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2015Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2016Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2015Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2015Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	9282981	shares
CY2015Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	9282981	shares
	us-gaap	Nature Of Operations NatureOfOperations	<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <b>1. Organization and Operations</b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif">  </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">Integrated Surgical Systems, Inc. (the “Company”) was incorporated in Delaware in 1990 to design, manufacture, sell and service image-directed, computer-controlled robotic software and hardware products for use in orthopedic surgical procedures.  On June 28, 2007, the Company completed the sale of substantially all of its operating assets.  After completion of the sale, the Company no longer engaged in any business activities related to its former business, described above. The Company’s current operations are limited to completing a business combination or strategic alliance, when a suitable candidate is identified.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The Company does not have an estimate as to when it will identify a qualified merger, acquisition, or strategic alliance candidate. There is no assurance that such opportunities will be available, or if available, upon favorable terms. If the Company is unsuccessful in completing a suitable merger, acquisition or strategic alliance, then the Board of Directors may liquidate the Company and distribute all its remaining assets, which consist primarily of cash and available-for-sale securities, to its stockholders.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The Company believes that if it identifies a suitable merger, acquisition or strategic alliance target, it will need additional capital to complete the transaction. The Company, at this time, cannot estimate the amount of financing it may need for a transaction. There is no assurance that it will be able to obtain any required funding for a transaction, or that if it is obtainable it will be on acceptable terms.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
	us-gaap	Use Of Estimates UseOfEstimates	<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><i>Use of Estimates</i></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif">  </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and revenues and expenses for the reporting period.  Actual results could differ from those estimates.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2016Q2	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	1372631	USD
	us-gaap	Available For Sale Securities Gross Unrealized Gains AvailableForSaleSecuritiesGrossUnrealizedGains	29414	USD
	us-gaap	Available For Sale Securities Gross Unrealized Loss AvailableForSaleSecuritiesGrossUnrealizedLoss	10891	USD
CY2016Q2	us-gaap	Available For Sale Securities AvailableForSaleSecurities	1391154	USD
CY2016Q2	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	1372631	USD
	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit	0.17
CY2016Q2	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions	175000	shares
CY2016Q2	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions	175000	shares
CY2015Q4	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	1770889	USD
CY2015	us-gaap	Available For Sale Securities Gross Unrealized Gains AvailableForSaleSecuritiesGrossUnrealizedGains	21141	USD
CY2015	us-gaap	Available For Sale Securities Gross Unrealized Loss AvailableForSaleSecuritiesGrossUnrealizedLoss	15845	USD
CY2015Q2	us-gaap	Incremental Common Shares Attributable To Conversion Of Preferred Stock IncrementalCommonSharesAttributableToConversionOfPreferredStock	1321537	shares

Files In Submission

Name	View Source	Status
0001144204-16-119184-index-headers.html	Edgar Link	pending
0001144204-16-119184-index.html	Edgar Link	pending
0001144204-16-119184.txt	Edgar Link	pending
0001144204-16-119184-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
issm-20160630.xml	Edgar Link	completed
issm-20160630.xsd	Edgar Link	pending
issm-20160630_cal.xml	Edgar Link	unprocessable
issm-20160630_def.xml	Edgar Link	unprocessable
issm-20160630_lab.xml	Edgar Link	unprocessable
issm-20160630_pre.xml	Edgar Link	unprocessable
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
v445790_10q.htm	Edgar Link	pending
v445790_ex10-1.htm	Edgar Link	pending
v445790_ex10-2.htm	Edgar Link	pending
v445790_ex31-1.htm	Edgar Link	pending
v445790_ex31-2.htm	Edgar Link	pending
v445790_ex32-1.htm	Edgar Link	pending
v445790_ex32-2.htm	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$AREN
Arena Group Holdings, Inc. Stock $aren

2016 Q3 Form 10-Q Financial Statement

#000114420416119184 Filed on August 15, 2016

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AREN Arena Group Holdings, Inc. Stock $aren

2016 Q3 Form 10-Q Financial Statement

#000114420416119184 Filed on August 15, 2016

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AREN
Arena Group Holdings, Inc. Stock $aren